ID   A375-C5
AC   CVCL_2294
SY   A375Cl-5
DR   cancercelllines; CVCL_2294
DR   Cosmic; 932715
DR   ECACC; 97011320
DR   Wikidata; Q54606776
RX   PubMed=2584706;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=A375-C5
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 22
//
RX   PubMed=2584706; DOI=10.4049/jimmunol.143.11.3538;
RA   Morinaga Y., Suzuki H., Takatsuki F., Akiyama Y., Taniyama T.,
RA   Matsushima K., Onozaki K.;
RT   "Contribution of IL-6 to the antiproliferative effect of IL-1 and
RT   tumor necrosis factor on tumor cell lines.";
RL   J. Immunol. 143:3538-3542(1989).
//